Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

898.95 +13.75 (+1.55%)
Official Closing Price Updated: 7:00 PM EDT, Apr 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,380,856
Open 888.20
Bid (Size) 917.40 (1)
Ask (Size) 918.68 (1)
Prev. Close 885.20
Today's Range 882.12 - 902.50
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.67%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Nasdaq, Dow Jones Futures Rise On Meta, Microsoft Results: Apple Earnings Loom, Analyst Doubts New Bull Run For Stock Markets
Notwithstanding the recent seven-session run, the S&P 500 Index ended April — a historically strong month — with a loss of 0.8%. 
Via Stocktwits
Topics Economy Stocks World Trade
Exposures Fossil Fuels Interest Rates Tariff
New Weight Loss Pill & Massive U.S. Investment Sends Eli Lilly Stock Soaring – Is It Too Late To Buy?
Eli Lilly, a pharmaceutical leader in obesity and diabetes treatment, is back in the spotlight, and for good reason. 
Via Talk Markets

Performance

YTD
+15.5%
+15.5%
1 Month
+8.8%
+8.8%
3 Month
+11.8%
+11.8%
6 Month
+6.2%
+6.2%
1 Year
+15.1%
+15.1%

More News

Read More
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Via Benzinga
Price Over Earnings Overview: Eli Lilly
Via Benzinga
Market Whales and Their Recent Bets on LLY Options
Via Benzinga
Eli Lilly's Stock Is Up 15% This Year, and Here's Why It Could Take Off Even More
Via The Motley Fool
Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?
Via The Motley Fool
Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain
Via The Motley Fool
What To Expect From Eli Lilly’s (LLY) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
WeightWatchers Stock Rockets After Partnership For Eli Lilly's Zepbound Drug: Retail Investors Very Optimistic
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Why Is WeightWatchers (WW) Stock Soaring Today
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Via Benzinga
Why Viking Therapeutics Stock Popped Again Today
Via The Motley Fool
Hims & Hers Stock Surges As It Collaborates With Novo Nordisk To Sell Weight Loss Drug Wegovy On Its Platform
Via Benzinga
WeightWatchers Integrates With Eli Lilly To Expand Access To Zepbound, Stock Skyrockets 110%
Via Benzinga
The S&P 500 Is Doing Something That Hasn't Been Seen in Nearly 100 Years. Here Are the 10 Most Important Stocks to Keep an Eye On.
Via The Motley Fool
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
WeightWatchers Bankruptcy Buzz Could Be A Strategy To 'Get A Better Deal With The Bonds,' Says Activist Investor
Via Stocktwits
Topics Bankruptcy
Exposures Financial Legal
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
Via Talk Markets
Topics ETFs Stocks / Equities
Why AbbVie Stock Trounced the Market Today
Via The Motley Fool
Plaintiff Sues Eli Lilly, Johnson & Johnson Over Alleged Breast Cancer Risk Linked To Antipsychotic Medications
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Sandoz CEO Richard Saynor Slams Proposal For Europe-Wide List Price For New Medicines, Says Report
Via Stocktwits
Topics Government Intellectual Property Lawsuit
Exposures Financial Intellectual Property Legal
Why Viking Therapeutics Stock Popped Today
Via The Motley Fool
Eli Lilly Stock Gets A Double Downgrade And Price Target Cut By HSBC Over Valuation, Competition Concerns
Via Stocktwits
Topics Lawsuit
Exposures Financial Legal
IBD 50's Top Seed, ADMA, Just Rocketed On A New FDA Approval
Via Investor's Business Daily
Exposures Product Safety

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 898.95
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 04/30/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.